Erasca Foundation plans sale of 8,333 ERAS shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca Foundation has filed to sell common stock of Erasca, Inc. under a Form 144 notice. The planned sale covers 8,333 shares of common stock through Merrill Lynch, with an aggregate market value of $157,637.52, and is expected on July 21, 2026 on NASDAQ. The Foundation previously received 10,193,557 shares as a donation from Erasca, Inc. on July 20, 2021 and has already sold 8,333 shares on May 15, 2026 for $84,528.29 and another 8,333 shares on June 15, 2026 for $117,476.95.
Key Figures
Key Terms
Form 144 regulatory
Securities To Be Sold regulatory
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Erasca (ERAS) disclose in this Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.